Shenandoah Acquisition Corp - Insider Non-Derivative Transactions at Sigilon Therapeutics, Inc. (SGTX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Aug 11, 2023, Shenandoah Acquisition Corp's relationship to Sigilon Therapeutics, Inc. (SGTX) is TenPercentOwner, and currently has 100 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SGTX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Shenandoah Acquisition Corp - Insider Non-Derivative Transactions of SGTX Common Stock

Shenandoah Acquisition Corp - Insider Non-Derivative Transactions at SGTX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Aug 12, 2023	P -- (Common Stock)	1718493	14.92	100